News and Trends 14 Mar 2023
Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline
Pfizer Inc. is set to acquire Seagen Inc. for $229 in cash per Seagen share for a total enterprise value…
Mergers & acquisitions
- Latest Posts
News and Trends 13 Mar 2023
Sanofi adds diabetes drug through Provention Bio $2.9B acquisition
Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type…
Expert Advice 2 Mar 2023
5 steps to strategic partnerships for healthtech startups
By Varvara Melikhova, founder and CEO of Unison Innovations Strategic partnerships are a better way to build a product’s capabilities…
News and Trends 28 Feb 2023
GC Biopharma acquiring hemophilia rare disease pipeline
GC Biopharma Corp., a South Korean provider of biopharmaceutical products, has signed an asset purchase agreement with Catalyst Biosciences to…
ADVERTISEMENT
News and Trends 2 Feb 2023
Crown Bioscience acquiring Indivumed’s service business and biobank
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has entered into an agreement to…
News and Trends 11 Jan 2023
Five key trends shaping life sciences in 2023
By Kevin Wayer, president - government, education, infrastructure and life sciences industries, JLL, and Travis McCready, head of life sciences,…
News and Trends 11 Jan 2023
Clinical trends for 2023
By Richard Staines, account director, Optimum Strategic Communications Few would deny that the decade has had a turbulent start, but…
News and Trends 11 Jan 2023
What’s in store for biotech in 2023?
Perhaps 2022 will best be remembered in the life science industry for the return of many of the face-to-face events…
News and Trends 6 Jan 2023
Ensoma acquiring Twelve Bio
Arix Bioscience, a global venture capital company focused on investing in breakthrough biotechnology companies, announced that portfolio company Twelve Bio…
News and Trends 3 Jan 2023
Blacksmith Medicines merging with Forge Therapeutics
Blacksmith Medicines, Inc., and Forge Therapeutics have signed a definitive merger agreement. This will create a biopharma company dedicated to…
News and Trends 19 Dec 2022
Prenetics acquires ACT Genomics
Prenetics Global Limited is acquiring a majority stake in ACT Genomics Holdings Company Limited, an Asia based genomics company specializing…
News and Trends 8 Dec 2022
Polyplus announces completion of acquisition of Xpress Biologics to expand plasmid DNA
Polyplus has announced the completion of an acquisition of Belgian Xpress Biologics to expand plasmid DNA technology. Xpress Biologics specializes…
News and Trends 5 Dec 2022
New company Liminatus Pharma Inc to develop three cancer treatments
Clinical-stage biopharma company Liminatus Pharma LLC and Iris Acquisition Corp, a publicly traded special purpose acquisition company formed for the…
News and Trends 2 Dec 2022
Full-Life Technologies acquiring Focus-X Therapeutics
Full-Life Technologies, a global radiotherapeutics company, is acquiring New Jersey-based Focus-X Therapeutics, a company developing targeted radiopharmaceuticals to treat cancer…
News and Trends 30 Nov 2022
AstraZeneca splashes out up to $320M on T-cell receptor therapy company
Neogene Therapeutics, Inc., a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts),…
News and Trends 8 Nov 2022
GHO Capital and Vistria Group to acquire CDMO Alcami
Global Healthcare Opportunities, (GHO Capital Partners LLP), and The Vistria Group, have entered into a definitive agreement to acquire a…
ADVERTISEMENT
News and Trends 1 Nov 2022
Avista Capital Partners acquires Taconic Biosciences
Private equity company Avista Capital Partners has acquired Taconic Biosciences, a provider of genetically engineered research models (GEMs) and related…
News and Trends 1 Nov 2022
Citeline and Norstella merge to create $5B pharma technology company
Norstella has announced the completion of its merger with Citeline (formerly Pharma Intelligence). Upon closing, the $5 billion global company…
News and Trends 24 Oct 2022
Beckley Psytech acquires Eleusis Therapeutics
Beckley Psytech Limited has entered into a definitive agreement to acquire clinical-stage life science company Eleusis Therapeutics Limited in an…
News and Trends 24 Oct 2022
Syncona to acquire Applied Genetic Technologies Corporation
Healthcare company Syncona Limited says its newly established portfolio company has agreed to acquire, by a tender offer, all outstanding…
